Kingdon Capital Management, L.L.C. Praxis Precision Medicines, Inc. Transaction History

Kingdon Capital Management, L.L.C.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$0.83 - $1.18 $415,000 - $590,000	500,000 Added 10.64%	5,200,000 $5.98 Million
Q1 2023 May 15, 2023	BUY	$0.8 - $4.98 $1.48 Million - $9.18 Million	1,844,011 Added 64.57%	4,700,000 $3.81 Million
Q4 2022 Feb 14, 2023	BUY	$1.88 - $36.45 $3.2 Million - $62 Million	1,700,000 Added 147.06%	2,855,989 $6.8 Million
Q2 2022 Aug 15, 2022	BUY	$1.75 - $11.34 $1.3 Million - $8.41 Million	741,500 Added 178.89%	1,155,989 $2.83 Million
Q3 2021 Nov 15, 2021	BUY	$13.15 - $22.56 $2.16 Million - $3.71 Million	164,489 Added 65.8%	414,489 $7.66 Million
Q2 2021 Aug 16, 2021	BUY	$18.28 - $33.05 $4.57 Million - $8.26 Million	250,000 New	250,000 $4.57 Million

75K

Ticker PRAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,576,100
Market Cap $3.54B
Description
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of ...

Get notified when there are updates to the investment portfolio of Kingdon Capital Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Kingdon Capital Management, L.L.C. with notifications on news.